Delivery Order SPE2DB22D1017-SPE2DB25FG8DN
- Not listed
- The Defense Logistics Agency awarded a $8,026.53 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. As a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $8,026.53 to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets (30-tablet units) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, executed without a set-aside designation, was competitively awarded and represents a transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,254.18 to AmerisourceBergen Drug Corp for the supply of Promacta 25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of August 11, 2025. The contract utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This firm fixed-price contract, valued at $24,059.26, represents a non-competitive set-aside award and is scheduled for completion by August 11, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units, with a contract ceiling value of $12,029.63 and an ultimate completion date of August 11, 2025. This is a firm fixed-price delivery order issued under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Promacta 25 mg tablets (30-count units) valued at $4,418.06 under a firm fixed-price contract type. The award was made on July 21, 2025, with an ultimate completion date of August 11, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform...
- The Defense Logistics Agency awarded a $4,418.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Promacta 25 mg tablets (30-count units). The contract, which is a child delivery order under a larger indefinite delivery vehicle, carries an ultimate completion date of August 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PROMACTA 75 mg tablets (30-count units) on July 22, 2025, with a ceiling value of $24,059.26 and firm fixed pricing. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $4,418.06 to supply Promacta 25 mg tablets (30-count units) with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,492.89 Firm Fixed Price delivery order is for the drug Promacta 50 mg tablets, with a completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8DNDelivery Order
The Defense Logistics Agency awarded a $48,118.52 delivery order to AmerisourceBergen Drug Corp for the supply of Promacta 75 mg tablets (30-count units) with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's contract portfolio with DLA demonstrates substantial capability in delivering diverse pharmaceutical products across multiple therapeutic domains, positioning the company as a key provider within the federal medical supply chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.1k | 7/24/25 |